Viking Therapeutics, Inc (VKTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$35.53−$1.22 (−3.32%) on the dayAs of the close; data may be delayed.
VKTX price, last 12 months
Key stats
- Previous close
- $36.75
- Open
- $37.00
- Day range
- $35.10 – $39.05
- 52-week range
- $24.88 – $43.15
- Volume
- 13M
- Avg volume (20 days)
- 6.7M
- Market cap
- $4.4B
Performance
1W+22.6%
1M+3.3%
3M−6.6%
6M+3.7%
YTD+1.0%
1Y+33.4%
vs S&P 500, 1Y+16.6 pts
Technicals and fundamentals
About Viking Therapeutics, Inc
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $4.4B